B-cell lymphoma medical therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
(Mahshid)
 
(3 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{B-cell lymphoma}}
{{B-cell lymphoma}}
Please help WikiDoc by adding content here. It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.
{{CMG}}
==Overview==
 
==Treatment==
* Treatment includes radiation and chemotherapy.  
* Early-stage indolent B-cell lymphomas can often be treated with radiation alone, with long-term non-recurrence.
* Early-stage aggressive disease is treated with chemotherapy and often radiation, with a 70-90% cure rate.<ref name="mmhe">[http://www.merck.com/mmhe/sec14/ch177/ch177c.html Merck Manual home edition], Non-Hodgkin Lymphomas</ref>
* Late-stage indolent lymphomas are sometimes left untreated and monitored until they progress.
* Late-stage aggressive disease is treated with chemotherapy, with cure rates of over 70%.<ref name="mmhe">[http://www.merck.com/mmhe/sec14/ch177/ch177c.html Merck Manual home edition], Non-Hodgkin Lymphomas</ref>
 
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
Line 8: Line 17:
[[Category:Disease]]
[[Category:Disease]]
[[Category:Types of cancer]]
[[Category:Types of cancer]]
[[Category:Oncology]]
[[Category:Mature chapter]]
[[Category:Mature chapter]]
[[Category:Hematology]]
[[Category:Hematology]]
Line 14: Line 22:
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Hematology]]
[[Category:Immunology]]

Latest revision as of 02:26, 6 November 2017

B-cell lymphoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating B-cell lymphoma from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

B-cell lymphoma medical therapy On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of B-cell lymphoma medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on B-cell lymphoma medical therapy

CDC on B-cell lymphoma medical therapy

B-cell lymphoma medical therapy in the news

Blogs on B-cell lymphoma medical therapy

Directions to Hospitals Treating B-cell lymphoma

Risk calculators and risk factors for B-cell lymphoma medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Treatment

  • Treatment includes radiation and chemotherapy.
  • Early-stage indolent B-cell lymphomas can often be treated with radiation alone, with long-term non-recurrence.
  • Early-stage aggressive disease is treated with chemotherapy and often radiation, with a 70-90% cure rate.[1]
  • Late-stage indolent lymphomas are sometimes left untreated and monitored until they progress.
  • Late-stage aggressive disease is treated with chemotherapy, with cure rates of over 70%.[1]

References

  1. 1.0 1.1 Merck Manual home edition, Non-Hodgkin Lymphomas


Template:WikiDoc Sources